| Name | Title | Contact Details |
|---|
Forus Health is a medical technology start up founded in 2010 by a group of engineers with the goal to eradicate avoidable blindness. Over the years Forus Health has designed and developed affordable technology solutions to increase access and affordability of eye care. Our first product 3nethra classic is a compact and portable non-mydriatic fundus camera used for capturing digital images of the posterior (retina) and anterior (cornea) segments of the eye. The device is used for identifying common eye problems such as diabetic retinopathy, glaucoma, ARMD, cataract etc. The device is also integrated to a cloud based telemedicine platform which enables remote diagnosis. There are 40 million people who are blind globally, and 15 million live in India. The high incidence of blindness in India is due to a combination of several issues, but mostly due to limited access to eye care facilities, high cost of treatment/surgery and lack of awareness. The objective of Forus Health is to use technology to increase access, bring down the cost of diagnosis(affordability) and raise awareness (the three As). The key to our solution is not just the technology, but the way in which we have designed the deployment of the product.
MedCases Inc is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Discoveries to inspire the best life for every child and youth. The CHEO Research Institute is a not for profit corporation that connects exceptional talent and technology in pursuit of life-changing research for every child, youth and family in our community and beyond. We inspire trust in our research excellence by being curious, nimble, passionate and equitable.
At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.
American Medical Response (AMR) is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.